DEA Moves to Deny a Minneapolis Dispensary: What It Means
The DEA moved to deny In-Dispensary's federal registration over three parts of Minnesota law. What it means for patients, shops and Schedule III.
As of November 5, 2026. The Drug Enforcement Administration (DEA) has moved to deny federal registration to In-Dispensary, a licensed cannabis microbusiness in downtown Minneapolis. The DEA's order does not accuse the store of breaking any rule. It says three features of Minnesota's own cannabis law make it impossible for the agency to register any business operating under that law.
For Minnesota medical cannabis patients, nothing changes at the counter today. The Office of Cannabis Management (OCM, the state regulator) says the order does not affect state law and that medical cannabis remains available. What is at stake is federal: whether Minnesota businesses can get the lighter federal treatment that comes with Schedule III, including on taxes.
This guide explains what the DEA did, who it affects, what each side says and what happens next. It is general information, not legal advice. Business owners should consult counsel.
What happened
Medical marijuana moved to Schedule III in April
On April 23, 2026, the Attorney General issued an order under 21 U.S.C. 811(d) placing two kinds of marijuana in Schedule III of the Controlled Substances Act (CSA): marijuana in FDA-approved drug products, and marijuana handled under a state medical marijuana license. The order is published at 91 Fed. Reg. 22,714. Adult-use (recreational) marijuana was not part of it and stays in Schedule I. A broader rescheduling is moving through a separate federal proceeding.
Schedule III status is not automatic for a business. To get it, a state-licensed medical business has to apply for a DEA registration (the same kind of federal registration a pharmacy holds) and pass DEA's pre-registration investigation. Our Schedule III explainer covers what rescheduling does and does not change.
On Oct. 30, the first registrations, in seven states
On October 30, 2026, the Justice Department announced the first wave. More than 900 dispensaries were registered, all in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. The department called it "the first phase" and added a line that matters for Minnesota: "State licensure alone does not automatically grant federal registration." To qualify, it said, an applicant must operate under a state medical framework "consistent with federal law" and the country's treaty obligations.
Minnesota was not on the list. Cannabis Business Times, reporting on the same announcement, counted 30 Minnesota businesses among the timely applicants, including 26 dispensaries (Confidence: Medium, one Tier 2 source).
The same day, an order to In-Dispensary
That same week, the DEA served In-Dispensary, LLC with an order to show cause (a formal notice that the agency intends to deny an application, with the reasons, and a chance to respond). The Star Tribune first reported it, and owner Mark Eide confirmed it to the paper. A copy of the seven-page order is posted on DocumentCloud and linked by Marijuana Moment.
The order says In-Dispensary applied on or about May 27, 2026, to dispense medical marijuana in Schedule III, and that it holds an OCM microbusiness license. It then gives three independent grounds for denial. Each one is a feature of Minnesota law, not of the store.
The DEA's three reasons
| Ground in the order | The Minnesota law it points to | What the DEA says |
|---|---|---|
| One license, two markets | Minn. Stat. 342.51 lets a cannabis license holder add a medical cannabis retailer endorsement and serve patients alongside adult-use customers (the order cites former section 342.515, since renumbered 342.295) | The license falls outside the federal definition of a "state medical marijuana license" and lacks "robust protections" against diversion |
| Veterans without a written certification | Minn. Stat. 342.52, subd. 3 sets an alternative enrollment path for veterans | Dispensing without a practitioner's written certification conflicts with DEA rules and the Single Convention treaty |
| Lab-converted cannabinoids | Minnesota's medical product definitions allow artificially derived cannabinoids (Minn. Stat. 342.01 and 342.51) | The April order left synthetically derived THC in Schedule I, so dispensing it is diversion |
1. The dual-purpose license. Minnesota lets a cannabis business with a medical cannabis retailer endorsement serve both enrolled patients and adult-use customers. The DEA says selling to adult-use customers under the same license is, in federal terms, "per se diversion" (moving a controlled substance out of the legal channel), and that a regime built that way cannot meet its standard. The order states the conclusion broadly: the DEA "cannot permit any applicant" operating under Minnesota's regime into the federal system.
2. The veterans path. Minnesota law directs OCM to set up an alternative certification procedure for veterans. Under Minn. Stat. 342.52, subd. 3, OCM may ask a veteran for a copy of a veteran identification card and an attestation of a qualifying medical condition, instead of a health care practitioner's certification. The DEA says its rules require a signed certification from a practitioner, so dispensing on the veterans' attestation alone conflicts with federal law. Our medical card guide explains how enrollment works for everyone else.
3. Artificially derived cannabinoids. Minnesota's definition of a medical cannabinoid product can include artificially derived cannabinoids (cannabinoids chemically converted after extraction, such as THC made from CBD). The April order kept synthetically derived THC in Schedule I. The DEA says a regime that lets medical sellers dispense those products cannot be squared with the CSA.
Confidence: High for what the order says (Tier 1, the order itself and the Justice Department release). Medium for the reactions below (Tier 2, Star Tribune as relayed by a mirror and by Marijuana Moment, because startribune.com blocks automated reading).
Who it affects
Registered medical patients. No change today. Your registry status, your card and the state's medical tax exemption are set by Minnesota law, and OCM says the program carries on. The exemption from the cannabis and sales taxes at medical-endorsed stores is explained in our medical vs. adult-use tax FAQ.
Veterans enrolled through the veterans path. Your state enrollment is unchanged. The order names your enrollment route as one reason Minnesota businesses cannot be federally registered. It does not cancel any state registration.
Dispensaries with a medical endorsement. This is where the money question sits. A federal Schedule III registration is the gateway to treating medical sales as Schedule III activity, which matters for the federal tax rule known as 280E. Attorney Carol Moss told the Star Tribune the main effect is that businesses in dual-purpose states miss out on those tax advantages. Our 280E and Schedule III guide walks through why that rule affects shelf prices.
Adult-use only shops. The April order never covered adult-use sales, which remain Schedule I federally. This order does not change that.
Hemp drinks and gummies. None of this touches lower-potency hemp edibles. That is a separate federal story with its own date, covered in our December 11 federal hemp guide.
Both sides
The DEA and Justice Department's position. Federal registration is a privilege tied to federal law and to the United States' obligations under the 1961 Single Convention on Narcotic Drugs, which limits cannabis to medical and scientific use and calls for prescriptions. In the department's words, state licensure alone does not grant registration. The order argues that a license allowing medical and adult-use sales side by side lacks "robust protections" against diversion, that dispensing to veterans without a practitioner's certification conflicts with the treaty's prescription rule, and that dispensing lab-converted THC is handling a Schedule I substance. On that reading, the agency says registering a Minnesota applicant would be inconsistent with the public interest.
Minnesota and its defenders' position. OCM told the Star Tribune it received no communication from the DEA, that the order does not affect state law, and that medical cannabis remains available to patients. Gillian Schauer of the Cannabis Regulators Association said state regulators got no notice either, and raised open questions about how the DEA will coordinate with states. Attorney Neil Willner said the agency may be testing whether it can rule out an entire state rather than judge applicants one by one, which he described as a significant shift from the April order.
Neither side has said the other is acting outside its authority in a filed case. The legal test so far is the one in the order: whether In-Dispensary, or any Minnesota applicant, can show that registration is consistent with the public interest.
What's next
Scheduled. The order gives In-Dispensary 30 days from receipt to request a hearing and file an answer. If it does, the order sets a hearing before a DEA administrative law judge in Arlington, Virginia, on January 19, 2027, or a later date the judge sets. In-Dispensary may also send a corrective action plan to the DEA's Diversion Control Division. Moss told the Star Tribune she doubts either route would work, because the problem sits in state law rather than in the store.
Pending. The Justice Department says the DEA will keep issuing registrations in phases and is still reviewing applications from manufacturers and distributors, which need facility inspections and quota decisions. The broader rescheduling proceeding is separate and has not concluded.
Unknown. Whether other Minnesota applicants have received similar orders. Cannabis Business Times reported it was unclear. We have not seen OCM say how it will respond, or any proposal to change the state law the order cites. We will update this page when either happens.
Frequently asked questions
Can I still buy medical cannabis in Minnesota after the DEA order?
Yes. OCM says the order does not affect state law and that medical cannabis remains available to patients. The order is about federal registration for one business, not about the state program.
Why does the DEA order mention Minnesota veterans?
Minnesota lets veterans enroll in the patient registry through an alternative path: OCM may ask for a veteran identification card and an attestation of a qualifying condition instead of a practitioner's certification (Minn. Stat. 342.52, subd. 3). The DEA says federal rules require a practitioner's signed certification, so it lists that path as a reason it cannot register Minnesota businesses.
Is the DEA order the same thing as the December 11 hemp change?
No. The DEA order concerns state-licensed marijuana dispensaries and federal Schedule III registration. The December 11 change concerns hemp products such as THC seltzers sold under the federal hemp definition. They are separate laws with separate timelines.
What is a DEA order to show cause?
It is a formal notice that the DEA intends to deny or revoke a registration. It lists the agency's reasons and gives the business a chance to request a hearing before an administrative law judge, or to submit a corrective action plan, before a final decision.
Did other Minnesota dispensaries receive DEA denials?
We have not confirmed any. In-Dispensary's order is the only one made public as of November 5, 2026. Cannabis Business Times reported that 30 Minnesota businesses applied in the first window and that it was unclear whether others received similar letters.
Does federal Schedule III change what I pay at a Minnesota dispensary?
Not directly for shoppers today. Schedule III registration mainly changes how a business is treated under federal tax rule 280E. Any price effect would come through business costs, and Minnesota businesses do not have registrations.
Sources
- U.S. Department of Justice, "Justice Department Announces Issuance of Federal Registrations for Medical Marijuana Dispensaries," Oct. 30, 2026: justice.gov (Tier 1)
- DEA, Order to Show Cause, In the Matter of In-Dispensary, LLC: DocumentCloud (Tier 1, primary document published by Marijuana Moment)
- Minn. Stat. 342.52 (patient registry, subd. 3 veterans): Revisor (Tier 1)
- Minn. Stat. 342.51 (medical cannabis retailers and endorsement): Revisor (Tier 1)
- Minn. Stat. 342.01 (definitions): Revisor (Tier 1)
- Star Tribune, "Minnesota cannabis businesses won't benefit from federal medical marijuana changes," Oct. 30, 2026: startribune.com (Tier 2; read via MMJDaily's mirror)
- Marijuana Moment, DEA order on dual-licensing states, Oct. 30, 2026: marijuanamoment.net (Tier 2)
- Cannabis Business Times, DEA rules for Schedule III registrants, Nov. 2, 2026: cannabisbusinesstimes.com (Tier 2)
Last reviewed: November 5, 2026.
Want access to participating medical cannabis retailers?
$99 with code MNHUB. Provider certification comes before OCM enrollment review.
Explore Related Topics
News & Updates
Latest Minnesota cannabis news, legislative updates, and market reports
Medical Marijuana
Guide to Minnesota's medical cannabis program
Explore Medical MarijuanaGuides & How-Tos
Step-by-step Minnesota cannabis guides for buyers, patients, and growers
Explore Guides & How-TosGet the Minnesota Cannabis Brief
Dispensary openings, law changes, practical product guides, and worthwhile deals in one useful email.
Free. No spam. Unsubscribe anytime.
Related Articles
Related research
- Law changes
What the 2026 cannabis law (Laws 2026, chapter 123) changed in Minnesota Statutes chapter 342, and when each change takes effect, with links to the official text.
- Tax revenue
Minnesota reported $45.6 million in cannabis and hemp tax revenue for September 2025 through July 2026. The sourced figures, the 15% tax behind them, and where local aid went.
